S. De Wit

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

CD4+ Count–Guided Interruption of Antiretroviral Treatment

Reactive Oxygen Species in Inflammation and Tissue Injury

Incidence of Myocardial Infarction in Randomized Clinical Trials of Protease Inhibitor-Based Antiretroviral Therapy: An Analysis of Four Different Protease Inhibitors

Health care-associated infections – an overview

Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study

Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy

HIV infection, HAART, and endothelial adhesion molecules: current perspectives

Cardiovascular disease in patients with hemophilia

Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population

A global view of pulmonary hypertension

The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection

Updated Clinical Classification of Pulmonary Hypertension

Respiratory Symptoms and Airway Obstruction in HIV-Infected Subjects in the HAART Era

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS

Diagnosis, management, and treatment of hepatitis C: An update # † ‡

Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction

Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV

Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles

The Metabolic Syndrome and Cardiovascular Risk

The global burden of multiple chronic conditions: A narrative review

The end of AIDS: HIV infection as a chronic disease

Updated Clinical Classification of Pulmonary Hypertension

Metabolic Syndrome and Cardiovascular Risk in HIV-Infected Patients with Lipodystrophy

Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis

Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era

Prevalence of risk factors for cardiovascular disease in HIV‐infected patients over time: the Swiss HIV Cohort Study

Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

Antiretroviral Treatment of Adult HIV Infection

Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States

Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review

Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy**The sponsor provided the principal investigator with the results of study AI 424-008 before the study's subsequent publication but did not participate in the data analysis presented in this report. A draft of the manuscript was submitted to the sponsor before submission with the understanding that the final manuscript remained under the complete control of the principal investigator.

Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

Increase in Non-AIDS Related Conditions as Causes of Death among HIV-Infected Individuals in the HAART Era in Brazil

HIV infection and cardiovascular disease

Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis

Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases

Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion

Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus

Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries

Mechanisms of Antibiotic Resistance

Cardio- and cerebrovascular events in HIV-infected persons

Mitochondrial Dysfunction in Atherosclerosis

Combination Antiretroviral Therapy and the Risk of Myocardial Infarction

Circumcision and HIV Infection: Review of the Literature and Meta-Analysis

Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria

Sexually Transmitted Diseases Treatment Guidelines, 2010

Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection

The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D:A:D Study

Space, Knowledge and Power

Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Epidemiologists, social scientists, and the structure of medical research on aids in Africa

Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus

Male circumcision for prevention of heterosexual acquisition of HIV in men

The Metabolic Syndrome

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

Immunological functions of the human prepuce.

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

2020 International Society of Hypertension Global Hypertension Practice Guidelines

Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation

Guidelines for the management of hemophilia

Hospital Epidemiology and Infection Control in Acute-Care Settings

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Seroepidemiological study on sexually transmitted diseases and hepatitis B in African promiscuous heterosexuals in relation to HTLV-III infection

Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study